Viewing Study NCT01120561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:24 PM
Ignite Modification Date: 2026-01-30 @ 11:02 PM
Study NCT ID: NCT01120561
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2017-02-15
First Post: 2010-05-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
Sponsor: Genentech, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TDM-1 EAP View
None T-DM1 EAP View
None TDM1 EAP View
None Trastuzumab-MCC-DM1 EAP View
None Trastuzumab emtansine View
None EAP View
None T-PAS View